Team:BGU Israel/Achivements

From 2014.igem.org

(Difference between revisions)
(Created page with "{{Team:BGU_Israel/Menu}} <html> <section> <div style="height:12px"> </div> <div style="margin-bottom:10px"> <img src="https://static.igem.org/mediawiki/2014/b/b...")
 
(8 intermediate revisions not shown)
Line 12: Line 12:
     <div style="margin-bottom:10px"> <img src="https://static.igem.org/mediawiki/2014/b/b0/BGU14achievementsbanner.png" style="width:1079px" alt=""/></div>
     <div style="margin-bottom:10px"> <img src="https://static.igem.org/mediawiki/2014/b/b0/BGU14achievementsbanner.png" style="width:1079px" alt=""/></div>
-
<div class="col3" style="margin-right:20px;height: 150px; width: 505px;">
+
<div class="col3" style="margin-right:20px;height: 155px; width: 505px;">
         <h3 style="border-bottom:dashed;border-color:#000000">Human Practice Achievements<a href="#" onclick="goToByScroll('background'); return false;" class="right"></a></h3>
         <h3 style="border-bottom:dashed;border-color:#000000">Human Practice Achievements<a href="#" onclick="goToByScroll('background'); return false;" class="right"></a></h3>
-
         <p> </p>
+
         <p> We have established a campaign for students to volunteer in clinics and helped population at risk to acquire knowledge for healthy life style. Our main goal was to ensure continuity by put up a scholarship program.</p>
         </div>
         </div>
-
         <div class="col3" style="margin-right:16px; height: 150px; width: 505px;margin-right:0px">
+
         <div class="col3" style="margin-right:16px; height: 155px; width: 505px;margin-right:0px">
-
         <h3 style="border-bottom:dashed;border-color:#000000">Lab Achievements<a href="#" onclick="goToByScroll('test'); return false;" class="right"></a></h3>
+
         <h3 style="border-bottom:dashed;border-color:#000000">Lab Achievements<a href="#" onclick="goToByScroll('test'); return false;" class="right"></a></h3><br>
-
        <br>
+
four novel projects were proposed, offering treatments based on synthetic biology.
 +
     
         </div>
         </div>
<div class="clear"></div>
<div class="clear"></div>
Line 24: Line 25:
<div id="background" style="height:100px"></div>
<div id="background" style="height:100px"></div>
   
   
-
   <div class="textCont" style="height:740px;font-style: oblique;">
+
   <div class="textCont" style="height:1030px;font-style: oblique;">
       <h3 style="border-bottom:dashed;border-color:#000000">Human Practice Achievements</h3>
       <h3 style="border-bottom:dashed;border-color:#000000">Human Practice Achievements</h3>
     <div class="col2">
     <div class="col2">
-
     <p>It was extremely important to us to leave a mark in our human practice activities; therefore we wanted to learn about relevant patients, and provide a comprehensive solution that might apply in the future.</p>
+
     <p>It was extremely important to us to lead high impact human practice (HP) activities in our area of research of metabolic syndrome. Our objectives were to identify and learn about the most relevant patients, and then to provide a comprehensive solution that might apply in the future.</p>
 +
 
 +
<p align="center"><img src="https://static.igem.org/mediawiki/2014/7/73/ACHIEVEMENTS_EDIT_2_.jpg" height="240"></p>
 +
 
     <ul class="check">
     <ul class="check">
-
     <li>Our <u>Bedouin Campaign </u>was a main part of our HP strategy and  built on 3 steps:</li>
+
     <li>Our <u>Bedouin Campaign </u> was a main part of our HP strategy, which was built on 3 steps:</li>
     </ul>
     </ul>
     <ol>
     <ol>
-
       <li><span dir="LTR"> </span><strong>Learning</strong> about the Bedouin community; understanding why the Bedouin sector  suffers more from diabetes comparing to other sectors in Israel. In our  research we first focused on similar features of the Bedouins to other indigenous people around the world. Features like rapid urbanization process  and shifting from traditional to modern life style. Secondly, we pointed out  some features that are unique for the Bedouin culture and religion practices.</li>
+
       <li><span dir="LTR"> </span><strong>Learning</strong> about the Bedouin community; understanding why the Bedouin sector  suffers more from diabetes compared to other sectors in Israel. In our  research, we first focused on similar features of the Bedouins to other indigenous people around the world. Features like rapid urbanization process  and shifting from traditional to modern life style. Secondly, we pointed out  some features that are unique for the Bedouin culture and religion practices.</li>
-
       <li><span dir="LTR"> </span><strong>Mapping  Barriers</strong> - after understanding the  complexity of the Bedouin society and culture, we looked deeper and mapped the  factors which prevented the Bedouins from taking action, and sometimes even  refuse to accept the insulin conventional treatment. We came out with one clear  answer - lack of awareness, both for ways to prevent diabetes, and for its  implications.</li>
+
       <li><span dir="LTR"> </span><strong>Mapping  Barriers</strong> - after understanding the  complexity of the Bedouin society and culture, we looked deeper and mapped the  factors which prevented the Bedouins from taking action, and sometimes even  refuse to accept the insulin conventional treatment. We came out with one clear  answer - lack of awareness, both for ways to prevent diabetes, and for its  implications on their health.</li>
-
       <li><span dir="LTR"> </span><strong>Taking action to save life- </strong>we have  produced 2 big events for the Bedouin community: &quot;Metabolic  Ambassadors&quot;- Diabetes Seminar for 40 medical Bedouin students and &quot;Healthy Cooking Workshop &amp; Early Detection Glucose Tests for Bedouins  Spouses&quot; that hosted more than 25 Bedouin women. Both events set goal to  raise awareness and motivation for taking action and save life. We also believe  that these events will set the ground for our Inner Doctor solution. When we presented  our project, after providing knowledge about diabetes, people were much more  open-minded to accept our approach.<strong></strong></li>
+
       <li><span dir="LTR"> </span><strong>Taking action to save life- </strong>we organized 2 big events for the Bedouin community: The &quot;Metabolic  Ambassadors&quot;- A Seminar on Diabetes for 40 medical Bedouin students and the &quot;Healthy Cooking Workshop &amp; Early Detection Glucose Tests for Bedouins  Spouses&quot; that hosted more than 25 Bedouin women. Both events set goal was to  raise awareness and motivation for taking action and save life. We also believe  that these events will set the ground for our Inner Doctor solution. When we presented  our project, after providing knowledge about diabetes, people were much more  open-minded to accept our approach.<strong></strong></li>
     </ol>
     </ol>
    
    
Line 43: Line 47:
    
    
   <div class="col2" style="margin-left:15px">
   <div class="col2" style="margin-left:15px">
-
     <p>We couldn't make it without Dr. Abu-Rabia, the first Bedouin doctor in the Negev who helped us build and adjust our events within the community, according to their needs. We worked hard to involve partners in our process, like the Israeli Diabetes Association (IDA) and local clinics, to ensure the continuity of our accomplishment after the iGEM competition ends</p>
+
     <p>All these activities were performed with the great help of Dr. Abu-Rabia, the first Bedouin MD doctor in the Negev, who helped us build and adjust our events within the community, according to their needs. We worked hard to involve additional partners in our process, like the Israeli Diabetes Association (IDA) and local clinics, to ensure the continuity of our accomplishments in the future.</p>
     <ul class="check">
     <ul class="check">
-
     <li>Another major achievement was our success of establishing 8 scholarships for Bedouin students who will volunteer in diabetes clinics, and 1 scholarship for a Bedouin student who will participate in opening, for the first time, a branch of the Israeli Diabetes Association in the Bedouin sector. Dr. Abu-Rabia defined this news "no less than a revolution". </li>
+
     <li>Another major achievement was our success in establishing 8 scholarships for Bedouin students who will volunteer in diabetes regional clinics, and additional 1 scholarship for a Bedouin student who will participate in opening, for the first time, a branch of the Israeli Diabetes Association in the Bedouin sector. Dr. Abu-Rabia declared these news as "no less than a revolution". </li>
     <br>
     <br>
-
     <li>We also produced an expert's panel on Innovation 2014 Day, under the title: The Metabolic Syndrome - Could Synthetic Biology Provide a Breakthrough Solution? We were over-booked and attracted a diverse audience from the public and business sectors, and of course, doctors and students. All panel speakers came voluntarily and willingly in view of the importance of the subject.</li>
+
     <li>We also organized an expert's panel for the general public, held during the Innovation 2014 Day of Ben-Gurion University and it's title: The Metabolic Syndrome - Could Synthetic Biology Provide a Breakthrough Solution? We were over-booked; the seminar attracted a diverse audience from the public and business sectors, and of course, doctors and students. All panel speakers came voluntarily and willingly in view of the importance of the subject.</li>
     <br>
     <br>
-
     <li>We set numerous meetings, presented the iGEM competition and our project, consulted and discussed our treatment with a variety of stakeholders and opinion-makers: university leaders, public figures, doctors, CEOs and more. Among them were the Israeli Minister of Health; Mayor of Be'er-Sheva; Ben-Gurion University President; Metabolic Syndrome experts; CEO of IDA and CEO of Trigger Foresight (Deloitte).<div id="test"></div> Every meeting added a different piece to the puzzle - patient profiles, law and regulation, the business aspect and more – to a whole picture.</li>
+
     <li>We set numerous meetings, presenting the iGEM competition and our project; consulted and discussed our suggested treatment with a variety of stakeholders and opinion-makers: university leaders, public figures, doctors, CEOs and more. Among them were the Israeli Minister of Health; The Mayor of Be'er-Sheva; Ben-Gurion University President; Metabolic Syndrome experts; CEO of IDA and CEO of Trigger Foresight (Deloitte). Every meeting added a different piece to the puzzle - patient profiles, law and regulation, the business aspect and more– leading to a whole picture of Metabolic Syndrome and Treatment.</li>
     </ul>
     </ul>
        
        
Line 55: Line 59:
        
        
     </div>   
     </div>   
 +
  <div id="test" style="position:relative; bottom:70px"></div>
    
    
-
 
+
   <div class="textCont" style="height:510px; font-style: oblique;">
-
   <div class="textCont" style="height:400px; font-style: oblique;">
+
       <h3 style="border-bottom:dashed;border-color:#000000">Lab Achievements</h3>
       <h3 style="border-bottom:dashed;border-color:#000000">Lab Achievements</h3>
     <div class="col2">
     <div class="col2">
 +
<p>Realizing the complexity of the Metabolic Syndrome, we envisioned the need for multiple treatments. Thus, four novel projects were proposed, offering treatments based on synthetic biology.</p>
       <p><u>Intelligent Medication:</u><br>
       <p><u>Intelligent Medication:</u><br>
       <ul class="check">
       <ul class="check">
-
         <li> The system&rsquo;s parts have been designed and  synthesized.<br></li>
+
         <li> The system&rsquo;s parts were designed and  synthesized.<br></li>
-
       <li> All the systems parts have been assembled into CT26 eGFP cell line.<br></li>
+
       <li> All system parts were assembled into CT26 eGFP- transfactant mammalian cell line.<br></li>
         <li> We developed a software that automatically  designs scRNA constructs for specific mRNA dependent RNAi.<br></li>
         <li> We developed a software that automatically  designs scRNA constructs for specific mRNA dependent RNAi.<br></li>
-
         <li>Our results indicate an early proof of concept  - reduced eGFP expression in CT26 GFP expressing cells by using scRNA.</li></p>
+
         <li>Our results indicate an early proof-of-concept for reduced eGFP expression in CT26 GFP expressing cells after treatment with scRNA.</li></p>
       </ul>
       </ul>
       <p><u>Artificial Exercise:</u></p>
       <p><u>Artificial Exercise:</u></p>
       <ul class="check">
       <ul class="check">
-
       <li>The system&rsquo;s parts have been designed and  synthesized<br></li>
+
       <li>The system&rsquo;s parts were designed and  synthesized<br></li>
-
       <li> TMRM dye assay was achieved in order to perform a semi-quantitative analysis of mitochondria present in HepG2 cells.</li>
+
       <li> TMRM dye assay was established in order to perform a semi-quantitative analysis of mitochondria present in HepG2 cells (human hepatocytes cell line).</li>
     </ul>
     </ul>
     </div>
     </div>
Line 76: Line 81:
     <p><u>Aspiration Shift:</u></p>
     <p><u>Aspiration Shift:</u></p>
     <ul class="check">
     <ul class="check">
-
      <li> The system&rsquo;s parts have been designed and  synthesized.<br></li>
+
      <li> We produced a comprehensive mathematical  model of the circuit, to predict treatment effects.</li>
-
      <li> We produced a comprehensive mathematical  model of the circuit</li>
+
       </ul>
       </ul>
     <p><u>Biobricks:</u></p>
     <p><u>Biobricks:</u></p>
-
     <p>The  following biobricks were designed, characterized, and we currently work on  sending them to the registry: </p>
+
     <p>The  following Biobricks were designed, characterized, and we are currently working to send them to the Registry: </p>
     <ul class="check">
     <ul class="check">
       <li>Bba_K1458002 - UCP1  (Uncoupling protein 1) <br></li>
       <li>Bba_K1458002 - UCP1  (Uncoupling protein 1) <br></li>

Latest revision as of 00:03, 18 October 2014

Human Practice Achievements

We have established a campaign for students to volunteer in clinics and helped population at risk to acquire knowledge for healthy life style. Our main goal was to ensure continuity by put up a scholarship program.

Lab Achievements


four novel projects were proposed, offering treatments based on synthetic biology.

Human Practice Achievements

It was extremely important to us to lead high impact human practice (HP) activities in our area of research of metabolic syndrome. Our objectives were to identify and learn about the most relevant patients, and then to provide a comprehensive solution that might apply in the future.

  • Our Bedouin Campaign was a main part of our HP strategy, which was built on 3 steps:
  1. Learning about the Bedouin community; understanding why the Bedouin sector suffers more from diabetes compared to other sectors in Israel. In our research, we first focused on similar features of the Bedouins to other indigenous people around the world. Features like rapid urbanization process and shifting from traditional to modern life style. Secondly, we pointed out some features that are unique for the Bedouin culture and religion practices.
  2. Mapping Barriers - after understanding the complexity of the Bedouin society and culture, we looked deeper and mapped the factors which prevented the Bedouins from taking action, and sometimes even refuse to accept the insulin conventional treatment. We came out with one clear answer - lack of awareness, both for ways to prevent diabetes, and for its implications on their health.
  3. Taking action to save life- we organized 2 big events for the Bedouin community: The "Metabolic Ambassadors"- A Seminar on Diabetes for 40 medical Bedouin students and the "Healthy Cooking Workshop & Early Detection Glucose Tests for Bedouins Spouses" that hosted more than 25 Bedouin women. Both events set goal was to raise awareness and motivation for taking action and save life. We also believe that these events will set the ground for our Inner Doctor solution. When we presented our project, after providing knowledge about diabetes, people were much more open-minded to accept our approach.

All these activities were performed with the great help of Dr. Abu-Rabia, the first Bedouin MD doctor in the Negev, who helped us build and adjust our events within the community, according to their needs. We worked hard to involve additional partners in our process, like the Israeli Diabetes Association (IDA) and local clinics, to ensure the continuity of our accomplishments in the future.

  • Another major achievement was our success in establishing 8 scholarships for Bedouin students who will volunteer in diabetes regional clinics, and additional 1 scholarship for a Bedouin student who will participate in opening, for the first time, a branch of the Israeli Diabetes Association in the Bedouin sector. Dr. Abu-Rabia declared these news as "no less than a revolution".

  • We also organized an expert's panel for the general public, held during the Innovation 2014 Day of Ben-Gurion University and it's title: The Metabolic Syndrome - Could Synthetic Biology Provide a Breakthrough Solution? We were over-booked; the seminar attracted a diverse audience from the public and business sectors, and of course, doctors and students. All panel speakers came voluntarily and willingly in view of the importance of the subject.

  • We set numerous meetings, presenting the iGEM competition and our project; consulted and discussed our suggested treatment with a variety of stakeholders and opinion-makers: university leaders, public figures, doctors, CEOs and more. Among them were the Israeli Minister of Health; The Mayor of Be'er-Sheva; Ben-Gurion University President; Metabolic Syndrome experts; CEO of IDA and CEO of Trigger Foresight (Deloitte). Every meeting added a different piece to the puzzle - patient profiles, law and regulation, the business aspect and more– leading to a whole picture of Metabolic Syndrome and Treatment.

Lab Achievements

Realizing the complexity of the Metabolic Syndrome, we envisioned the need for multiple treatments. Thus, four novel projects were proposed, offering treatments based on synthetic biology.

Intelligent Medication:

  • The system’s parts were designed and synthesized.
  • All system parts were assembled into CT26 eGFP- transfactant mammalian cell line.
  • We developed a software that automatically designs scRNA constructs for specific mRNA dependent RNAi.
  • Our results indicate an early proof-of-concept for reduced eGFP expression in CT26 GFP expressing cells after treatment with scRNA.

Artificial Exercise:

  • The system’s parts were designed and synthesized
  • TMRM dye assay was established in order to perform a semi-quantitative analysis of mitochondria present in HepG2 cells (human hepatocytes cell line).

Aspiration Shift:

  • We produced a comprehensive mathematical model of the circuit, to predict treatment effects.

Biobricks:

The following Biobricks were designed, characterized, and we are currently working to send them to the Registry:

  • Bba_K1458002 - UCP1 (Uncoupling protein 1)
  • Bba_K1458003 – Heat Shock Protein70 promoter (HSP70)
  • Bba_K1458004 - Human AdipoQ
  • Bba_K1458005 – Human DsbA-L (GSTK1)